TransEnterix Inc. shares soared in the extended session Friday after the Food and Drug Administration gave marketing clearance to the company’s robotic surgery device. TransEnterix shares jumped 63% to $2.38 on after-hours volume of more than 1 million shares. Late Friday, the FDA announced it had granted marketing clearance to TransEnterix’s Senhance System that gives surgeons a 3-D high-definition view of the surgical field and remote control of three robotic arms to perform procedures.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News